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The experiments that  will be described demonstrate that myeloid 
leukemia of a mammal (mouse) is transmissible and is a neoplasm that 
affects the precursors of granular leukocytes, the same cells producing 
myeloid leukemia and  myeloma.  Snijders  (1)  has shown that  lym- 
phatic  leukemia  of  guinea  pigs  is  transmissible,  and  independent 
studies  of subsequent  workers found  this  to  be  true  for lymphatic 
leukemia  of  mice  (2-5).  The  isolation  of  the  strain  of  myeloid 
leukemia here described has made possible a study of the pathogenesis 
of myeloid leukemia and its relation to myeloma, and has made avail- 
able a constant source of malignant myeloid cells. 
Origin of Strain 
Routine examination of our colony revealed a mouse (No. Ar 117) 
with a greatly enlarged and readily palpable spleen; some of the lymph 
nodes of this mouse were slightly enlarged.  The leukocyte count was 
103,000  per  c.mm.;  most  of  these  white  blood  cells  were  myeloid 
cells but only 9.5 per cent of them were myelocytes with coarse baso- 
phile  granules  that  were  subsequently  identified  as  the  malignant 
myeloid cells characteristic of this strain  (Figs.  1 to 3). 
Neutrophile polynuclear leukocytes were 31 per cent, neutrophile myeiocytes 
and metamyelocytes 20 per cent, eosinophile g~nuloeytes 0.5 per cent, ceils like 
monocytes 17 per cent, cells like monocytes with basopbile cytoplasm (Fig. 1) 
11.5 per cent, lymphocytes 10.5 per cent.  The great  enlargement of the spleen 
was due  to infiltration  with myelocytes containing coarse  basophfle granules 
* This investigation has been supported by a Fund for the Study of Leukemia. 
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(Fig.  19).  The pulp was densely packed with these cells and the lymphoid tissue 
atrophied.  The liver was moderately enlarged and its sinusoids  were distended 
with basophile mydocytes (Fig.  17).  The femoral marrow was a  dense mass of 
these cells (Fig. 22).  The structure of the lymph nodes was retained but basophile 
mydocytes filled their sinuses (Fig. 20).  Wherever found, many of these mydoid 
cells were in the process of mitotic division.  Their abundant, coarse granulation, 
stained purple to black with Azure II, made them readily recognizable  in  any 
location. 
TABLE  I 
Transmission  of Spontaneous Mydoid Leukemia 
Mice 
Unrelated (R), irradiated ..... 
Unrelated (R), irradiated ..... 
Related (Ar), not irradiated... 
Related (Ar), not irradiated... 
Route of injection 
i.v. 
Intrasplenic (?) 
i.V. 
Intrasplenic (?) 
No. of! 
mice 
jected 
Length of life of mice with 
myelosis 
days 
K 18, K 20, K 25 
K 27,K 31,K 48, D 50 
K49 
D 66, D 109 
Abbrevialions Used in the Tables 
q-  ffi inoculation successful;  K  ffi killed;  D  ffi died.  "Length of life" means 
length of life of mice with myelosis, in days, after inoculation; e.g., "K 18" means 
a mouse with mydosis killed 18 days after inoculation.  With rare exceptions mice 
were killed only in extremis. 
Route of inoculations:  i.v.  =  intravenous; s.c.  =  subcutaneous; i.p.  =  intra- 
peritoneal. 
"Irradiated" signifies that the entire body of the ~nlmal was irradiated from 
1 hour to 5 days before inoculation, with 400 r-unlts of X-rays, using the following 
factors:  190 kv., 30 am., 50 cm. distance, 0.5 ram. Cu  -I- 1 ram. A1.  The mice 
were irradiated by Mr. E. Stober through the courtesy of Dr. J. R. Carty in the 
Department of Radiology, Comell Medical College. 
Transmission of the Leukemia 
The  mouse  was  breathing  with  difficulty;  it  was  killed  and  an 
emulsion of the spleen injected  into  twenty mice of which  eight were 
irradiated  1  day before inoculation.  Twelve mice received injections 
into the tail vein, and in another group of eight mice an attempt was 
made to inject the material directly into  the  spleen,  which is readily 
visible beneath the shaved and moistened skin.  The results of these 
inoculations  are summarized in Table I. j.  ~UST~  425 
The n~terlal  of study,  the technic  of inoculation  and of irradiation,  and the 
stocks  of mice used have been described  (5). All  mice used in this  study were 
bred in our laboratory  and are members of one of three  different  stocks  named 
A, R, and S.  These stocks  have  been  inbred  since  1928,  and were  split  up into  a 
number of families  that were derived from brother and sister  matings. These 
f~miHes  were  designated  by  adding  small  letters  to  the  capitals  A,  R,  and  S.  Mem- 
bers  of  the  different  stocks  (/I,  R,  and  S)  are  regarded  as  being  unrelated,  members 
of  the  same  family (e.g.,  At) as  being  related. 
The medium used in the preparation  of cell  suspension  was either  Tyrode or 
Locke  solution. The  intravenously injected  cell  suspension contained from 
30,000 to 100,000 leukocytes  per c~rnrn,  and was injected  in amounts of 0.1 cc. 
Mice that  appeared  healthy  were  killed  from  80  to  150  days  after  inoculation. 
Three  of  the  four  irradiated  mice inoculated  intravenously  were  very  ill  about 
2 weeks after  inoculation;  they had enlarged  spleens  and numerous basophilc 
myelocytes in  the  blood.  On  postmortem examination all  showed  diffuse  myelosis 
and  material  from  these  mice  transmitted  the  disease  to  most  of  the  mice  inoculated 
with  it.  The  similarly  inoculated,  unirradlated,  but  related mice  remained 
healthy  with the  exception  of  one  mouse that  developed a nodular swelling  about 
I  cm. in  diameter  in  the  submaxillary  region. This  was thought  to  be  an  abscess 
and  the  mouse  was  killed  49  days  after  injection;  but  autopsy  showed that  it  was  a 
growth composed entirely  of  basophile  myelocytes.  S~mi|~r  nodules were found 
in the abdominal muscles,  diaphragm, and lungs,  and there  was a diffuse  micro- 
scopic  infiltration  of the spleen  and liver  by basophile  myelocytes,  but the  ante- 
mortem blood smear was normal.  The six mice successfully  inoculated  intra- 
splenically  developed small  nodules  in  the  subcutaneous tissue  at  the  site  of  needle 
puncture,  and extensive  abdominal myelomatosis.  Antemortem invasion  of the 
blood by basophile  myelocytes was seen  in two of  these  mice.  The spleens  and 
livers  appeared to be normal, or showed slight  diffuse  or nodular inAltrations. 
The course  of the disease  was slow in the unirradlated  mice and they died from 
2 to  3 months after  the  injection. 
The inference was drawn  from this experiment  that the discase is 
more  readily  transmitted  to  irradiated than  to  unirradiated  mice. 
In further subpassages  irradiated mice  wcrc  used to propagate this 
strain  of myeloid  leukemia  and  unirradiated  mice  of  the  diffcrcnt 
stocks to test their susceptibility.  In order to establish the optimal 
conditions of transfer and the anatomical changes under the various 
conditions of inoculations,  the route of inoculation was varied, and 
different tissues were used for injection. 
Subsequent work has shown that the discasc is  readily  transmissible 
by tissues containing live basophilc myelocytes; but transmission fails 
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directly seemed superfluous, for it was evident that  these malignant 
myeloid cells  would grow in  the  subcutaneous  tissue  or in  the  ab- 
dominal cavity and form tumors in these sites  (Figs.  8,  9).  Neither 
the individuality of the host nor the site of inoculation modified the 
characteristics of these malignant myeloid cells. 
Table II is a summary of fourteen intravenous passages in irradiated 
mice and shows that the inoculations were successful in 88.6 per cent 
of the animals.  The inoculations in irradiated mice by routes other 
than intravenous  (Table  III)  were somewhat less successful (78  per 
cent).  In four of the mice included among the successful inoculations 
in  this  table  the  growth  that  developed  at  the  site  of inoculation 
regressed.  The anatomical changes in relation to the route of injec- 
tion will be dealt with later. 
Nodular growth about the sternum, vertebrae, and kidney, found in the mice 
of the first passages, suggested  the attempts of producing such nodules by injecting 
a suspension of immature mydoid cells about these tissues.  These inoculations 
resulted in the formation of growths at the site of injection and they were aban- 
doned as soon as it was recognized  that similar growth may be readily produced in 
the subcutaneous tissue and abdominal cavity. 
It requires a long period for the malignant myeloid cells to form a 
grossly  detectable  growth,  when  introduced  into  the  subcutaneous 
tissues; but similar cells produce fatal myeloid leukemia within from 
2  to  3  weeks  when  introduced  intravenously.  Barely  detectable 
nodules were occasionally found in the subcutaneous tissue 2 months 
after inoculation with fairly large doses, and it is probable  that  the 
incubation  period  can  be  prolonged  by  decreasing  the  inoculating 
dose.  These  data  are of interest in  relation  to  the long period  of 
latency of some malignant neoplasms. 
Inoculations are less often successful in unirradiated than in irra- 
diated  mice and  the  disease  produced is  more chronic  (Table  IV). 
Direct offspring of the mouse with the spontaneous disease  (No. Ar 
117) were not available for inoculation.  Forty-one mice that could be 
traced back to the same parents as No. Ar 117  (Stock Ar) were tested 
and sixteen (39 per cent) proved susceptible; of forty unrelated mice 
(Stocks  R  and  S)  tested,  six  (15  per  cent)  proved  susceptible 
(Table IV). TABLE  II 
In~rarenous Inoculations of Irradiated  Mice 
No. of 
passages 
I 
II a 
II b 
II c 
II d 
II e 
IIIa 
III b 
III h 
IIIf 
III i 
IIIj 
III k 
IVc 
Material injected  No. of mice  injected  No. + 
Spleen  4  3 
;  "  12  10 
"  14  13 
Spleen (diluted)  10  8 
Spleen  12  11 
Growth  8  8 
"  8  8 
Spleen  4  4 
Blood cells  9  9 
Spleen  4  4 
Spleen (i.v. and s.c.)  7  7 
Spleen  4  0 
"  8  7 
"  3  3 
Spleen (diluted)  11  10 
Growth  9  9 
Growth and spleen  3  3 
Spleen  2  0 
Total ....  132 
Length of life of mice with 
myelosis 
Extremes  Average 
days 
K  18 to 25 
K  17 to 21 
D 20 to 48 
K 21 to 22 
D  16 to 47 
K 83 
D 27 to 48 
D 20 to 24 
K 25 
D  18 to 25 
D  28 to 54 
K21 
D 21 to 24 
D 14 to 32 
D  15 to 23 
K 29 to 41 
D 21 to 25 
K63 
D  18 to 22 
K  15, D 15 
K  72 to 95 
D 34 to 96 
D 22 to 45 
K 22 
D 20 to 32 
days 
K 21 
K  20 
D 27 
K 22 
D 26 
K 83 
D 36 
D 22 
K  25 
D 21 
D 37 
K 21 
D 22 
D 23 
D 20 
K 33 
D 24 
K63 
i  D  20 
i 
K84 
D 59 
D 33 
K 22 
D 27 
117  (88.6 per cent) 
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TABLE  III 
Inoculations  Other than Intravenous  in Irradiated  Mice 
NO. of 
~auages 
II  a 
II b 
II c 
II d 
II  e 
IIf 
III a 
III c 
llI d 
III g 
IV b 
IV d 
Route of injection 
i.p. 
i.p. 
S.C. 
S.C. 
S.C. 
Intrasplenic (?) 
Perirenal 
S.C. 
$.¢. 
S.£. 
S.C. 
S.C. 
Perivertebral 
Peristernal 
S.£. 
s.c. and i.p. 
s.c.  and i.p. 
i.p. 
Material injected 
Spleen  4 
"  3 
"  3 
"  13 
"  4 
Growth  6 
"  5 
"  6 
"  4 
"  6 
Spleen  4 
Spleen*  5 
Spleen  5 
"  2 
Growth  7 
Growth and spleen  4 
"  "  "  4 
10 
Total... 
No. oJ  Length of life of mice with 
mice  myelosis 
in- 
jected  Extremes  Average 
days  days 
K27 to48 
D 5O 
D49 to 79  D69 
K 3O 
Dlllto14~  D128 
K 64 to 78  K  70 
D 49 to 141  D  106 
D 34 to 101  D 72 
D 43 to 62  D 52 
D 40 to 120  D 61 
K 55 
D115to141  D132 
D 53 to 116  D 92 
K  70 to 98  K 84 
K 69, D 90 
K 87 
D 26 to 31  D 29 
D 32, K 34 
K 84 to 125  K or D 87 
D 43 to 95 
K  109 
K 70  K or D 57 
D 31 to 105 
95  74 (78 per cent) 
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Attempts  at  Transmission  with  Material  Free from  Viable  Cells 
Four different procedures that served best to demonstrate the exist- 
ence of viruses capable of transmitting leukosis of chickens were used 
to  determine  whether  the  myeloid  leukemia  Strain  Ar  117  can  be 
TABLE  IV 
Inocugation in Unirradiated Mice 
Stock 
of mice 
Ar 
Ara 
Arc 
Af 
Ak 
Rg 
Rf 
S 
No. of 
passages 
I 
I 
II d 
II d 
IIf 
III d 
III d 
III d 
II e 
He 
III b 
II e 
HI a 
II ¢ 
III  a 
IIIf 
III  e 
Route of injection 
i°v. 
Intrssplenic  (?) 
Perirenal 
S.C. 
S.C. 
S.C. 
S.C. 
S.C. 
i.V. 
S.C. 
i.v. 
i.v, 
i.v. 
S,C. 
S.C. 
i.v. 
i.v. and s.c. 
Length of life of mice with 
myelosis 
days 
K49 
D 66 to 109 
D 37 to 67 
D 129 to 145 
D 55 
D 73 to 123, K 122 
D48 
D63 
D 136 
Extremes  Average 
days 
D  84 to 85 
D  135 
D  116 
I  I 
Stock Ar, Ara, Arc ..............  41  16 (39 per cent) 
Other stocks ....................  40  6  (15 per cent) 
D  88 
D 51 
D 137 
D  85 
* One  mouse  with  transmitted  myeloid tumor  is  still  alive,  208  days  after 
inoculation. 
transmitted  by  material  free  from viable  cells.  These  experiments, 
summarized in  Table V,  indicate  that  Strain  Ar  117  is  transmissible 
only by viable ceils.  Not a  single finding was to the contrary.  Some 
of these experiments merit further discussion. 
Freezing  and  Thawing.--Tlfis  procedure  has  often  been  used  in 
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led  to  erroneous  conclusions,  probably  because  of  faulty  technic 
(cJ.  5).  It is essential to seal in a test tube  the material to be frozen, 
to submerge it in a liquid that is chilled to known temperature, and to 
TABLE  V 
Inoculations with Material Free from Viable Cells 
Material injected 
I 
(a) Plasma 
(b)  " 
II 
(a)  Dried tumor and spleen 
(b) Dried spleen 
III 
(a)  Growth frozen at 
--30* during 30 rain. 
(b) Spleen frozen at 
--30* during 30 rain. 
--200 during 30 rain. 
--15  ° during 30 rain. 
(c)  Growth frozen at 
-35 ° during 30 rain. 
IV 
Glyeerinated spleen (7 to 21 
days) 
Route of 
injection 
i.v. 
i.v. 
s.c. and i.p. 
i.v. 
S.C. 
S.C. 
S.C. 
S.C, 
i.v. 
S.C. 
Total  ............................... 
Control 
Material injected  ~  o  4- 
s.~q 
Blood cells, 1/2"  5  ] 5 
"  "  1/20  4  4 
"  "  1/2  3  2 
"  "  1/20  4  3 
"  "  1/400  3  i 
Before drying  4  1 
"  "  3  3 
Not frozen  6  6 
Frozen at  4  4 
--10  ° during 30 rain. 
--5  ° during 30 rain.  3  3 
Not frozen  3  3 
Fresh, 1/1"  3  3 
"  1/20  3  3 
"  1/400  3  3 
Immediately after glyc-  5  2 
erination 
Total. 
* Dilutions. 
keep the material at this temperature during a  period of time neces- 
sary for a~l cells to reach approximately this temperature.  When sub- 
jected to such treatment the malignant myeloid cells, like malignant J.  I~URTH  431 
lymphoid  cells,  are  destroyed  at  a  temperature  between  -10 °  and 
-15°C.  during  30  minutes  (Table  V,  Experiment  III b).  Many 
ceils are,  however, injured  at  a  temperature  above this  critical  tem- 
perature,  as indicated by the length of life of the inoculated animals. 
Material injected 
Fresh ..................................... 
At -5°C. during 30 rain  .................... 
At --10°C. during 30 rain  ................... 
Length of life of mice with myelosis 
Individual  figur~ 
days 
D 37, D  51, K 54 
D 31, D  57, K 70 
K 52, D 55, D  58, D  105 
Average 
days 
48 
53 
68 
Since  the life is lengthened  by decreasing  the  inoculating  dose, it 
seems probable that many cells were injured by freezing at  -5 ° and 
-10°C.,  and  certainly  all  cells were  destroyed at a  temperature  of 
-15°C.  There  seems to be a  critical subzero temperature at which 
the cells die.  Experiment  IIIc  shows  that  the  unfrozen  suspension 
caused myelosis in all mice injected, even when the dilution was 1/400, 
and  data  obtained  from  subsequent  work  (Table  VI)  suggest  that 
the minimal dose producing myelosis is far below this quantity. 
Drying of the malignant  myeloid cells in vacuo while in the frozen 
state,  as described in previous reports  (5),  destroyed the agent  con- 
cerned with the transmission of myelosis. 
Plasma was obtained by spinning heparinized blood at a speed of about 1,000 
~.P.~. during  5 minutes, and  recentrifugalizing the plasma at a speed of about 
2,000 R.1,.~¢. during 15 minutes. 
Glycerination was brought about by adding an equal volume of glycerine (e.1,.) 
to the cell suspension.  The  experiment shown in  Table  V is of limited value 
because it was terminated by error 80 days after inoculation at a time when the 
tumors in the control mice were still small. 
Relation  of Dose to the Success of Inoculations;  Observations on the 
Relation of Myeloma to Diffuse Myelosis 
Qualitative experiments in search for a filterable agent, such as those 
shown in Table V, might depend for their success largely on the con- 
centration  of the supposed agent in  the initial  material.  It was de- 
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success of inoculation, for another reason.  When a cell suspension was 
used for intravenous inoculation, mice that died soon after inoculation 
TABLE  Vl 
Intravenous Inoculation with Decreasing Doses 
Material injected 
(a) Blood cells 
(b)  Blood cells 
(c) Spleen 
(d)  Growth 
(e) Growth and spleen 
Of) Growth and spleen 
(g) Growth and spleen 
Concentration 
of ineculum 
~/1 
1/2o 
1/1 
1/2o 
1/4oo 
1/1 
1/2o 
1/4oo 
1/8,000 
1/1 
1/20 
1/400 
1/1 
1/5o 
1/2,500 
1/125,000 
1/1 
1/so 
1/2,500 
1/1 
1/lOO 
1/10,000 
1/1 million 
1/100 million 
No. of 
mice 
in- 
jected. 
~o.  + 
5 
5 
2 
3 
1 
3 
3 
4 
3 
3 
3 
3 
3 
3 
5 
6 
Length of life 
D 14 
D 20 
Extremes 
days 
to 27 
to 32 
D 34 to 38 
D 51 to 59, 
D 55 
D  15, K  15 
D 34 to 42, 
D 35 to 77 
D 89 to 96, 
D  22 
D 34 
D 36 
D15 
D 22 
D 29 
K 41 
D48 
to 35 
to 36 
to 48 
to 18 
to 29 
to 35 
to 46 
to 65 
D  14 to 18 
D 20 to 29, 
D 24 to 31 
K  31 to 34 
D  17 to 21 
D 27 to 61 
D 39 to 81 
D 58 to 72 
A'~rage 
days 
D 22 
D 25 
D 36 
K 99  D or K 70 
D or K  15 
K 72  D  or K 45 
D 51 
K 95  D  or K 93 
D 27 
D 35 
D43 
D  17 
D27 
D 33 
K  or D 50 
D  18 
K 31  D or K 26 
t DorK29 
D  19 
D  orK44 
D52 
!  D72 
I 
with a  large dose showed diffuse leukemic myelosis, whereas  those that 
lived  long  often  died  with  multiple  myeloma,  but  with  no  diffuse j.  ~trRT~  433 
leukemic myelosis.  This observation indicated that resistance of the 
host as suggested by the lengthy course of the disease was the major 
factor  in  the  development  of  multiple  myelosis.  Nevertheless  it 
seemed  worth  while  to  determine  if  smaller  doses  would  produce 
myeloma, and larger  doses  diffuse  myelosis.  The  results  of  intra- 
venous inoculation with decreasing doses are summarized in Table VI. 
In the last experiment recorded in Table VI the concentrated cell suspension 
contained 110,000 leukocytes per c.mm. and the volume injected was 0.1 cc.; the 
mice injected with dilutions of 1/1,000,000 may therefore be estimated to have 
each received  approximately eleven cells.  In the remaining experiments the con- 
centrated cell  suspension contained from 30,000 to 100,000 leukocytes per c.mm. 
Most mice used in these experiments were rendered susceptible by a 
preceding irradiation with X-rays.  The degree of susceptibility in- 
duced by X-rays depends on the dose, and after a period of from I to 3 
weeks following irradiation it decreases considerably (cf.  5).  Hence if 
the life of the inoculated mice is lengthened by decreasing the amount 
of the inoculum, inoculations may become unsuccessful merely because 
the host is given time to regain the resistance lowered by irradiation. 
It is remarkable that life is only slightly prolonged by greatly de- 
creasing the inocu.lum and that the number of successful inoculations 
does not diminish with a delayed incubation period.  The supposition 
that the disease would fail to develop in resistant irradiated mice unless 
it appeared within a few weeks because these mice had regained their 
resistance, previously lowered by irradiation, was contradicted by the 
results of the  experiments.  A  single large dose of X-rays causes a 
more profound injury than hitherto suspected, or the resistance of the 
host  is  overcome by the multiplication  of malignant cells  during a 
transient period of lowered resistance.  The former assumption  finds 
support  in  the observations  that  the incidence of spontaneous lym- 
phomatosis  (6)  and myelomatosis  (7)  is  increased by a  single large 
dose of X-rays. 
The  following  experiment  (Passage  IIIi,  Experiment  c  of  Table 
VI) shows the relation of the length of life to the type of the disease. 
In this experiment, mice of Stock A were inoculated 3 days after irradiation 
with a splenic cell suspension from a mouse with myeloid leukemia.  The exact 
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120,000  white cells per cram., but the material had to be refiltered and  an  un- 
known  number of the cells were lost during this process.  Each mouse received 
0.1  cc. of cell suspension.  The inoculation was unsuccessful in one mouse that 
was killed 120 days after inoculation; all other mice died or were killed in extremis 
within 96 days after inoculation. 
Length of life  Dilution  of material  injected  Type of disease 
daN$ 
K15 
K15 
D15 
D34 
D35 
D42 
D42 
D $0 
K72 
D77 
D89 
K95 
D96 
K120 
1/1 
1/1 
1/1 
1/20 
1/400 
1/20 
1/400 
1/400 
1/20 
1/400 
1/8,000 
l/S,000 
1/8,000 
1/8,000 
Diffuse myelosis (myeloid leukemia) 
Multiple myeloma 
Myelonm 
4C 
Multiple myelonm 
Negative 
All mice that died within 50 days showed diffuse myelosis; all that 
lived for at least  72  days showed the formation of nodules attached 
to  bones  and  viscera.  These  masses  were  composed  of  immature 
myeloid cells infiltrating the surrounding tissue.  Mitotic figures were 
numerous  among  the  immature  myeloid  cells  and  there  was  no 
evidence  of  inflammation.  Hence  these  nodules  may  be  regarded 
as tumors (myelomata). 
The results of all other experiments shown in Table VI were essen- 
tially the same.  Tumors appeared in mice that received a small dose, 
whereas mice injected with a large dose developed diffuse myelosis with 
no tumor formation. 
These experiments suggest that the type of disease is largely deter- 
mined by the number of malignant myeloid cells entering the circula- 
tion.  Individual resistance as a  minor factor is suggested by a  few 
irregularities in the relation of dose to the time of death.  Since the 
resistance of all mice was very low at the beginning of the experiment, 
as  the  result  of  massive  irradiation  preceding  the  inoculation,  and j.  rtYaTH  435 
then gradually returned, it is questionable whether a  reduction of the 
inoculating dose did more than delay the incubation period.  Not until 
highly susceptible unirradiated mice are available for inoculation can 
the effect of the dose be accurately determined. 
The relation of resistance of the host to the type of disease becomes 
evident when mice with widely differing resistance, namely irradiated 
and unirradiated mice, are inoculated with the same dose. 
(a)  In the transmission experiment with material from the spontaneous  case, 
irradiated and unirradiated mice were inocuiated  intravenously with the same 
amount of cell suspension.  Irradiated mice: K 18, K 20, K 25, diffuse myelosis. 
Unirradiated  mice: K 49, mydoma; K 178 (six mice), negative. 
(b)  Passage IIe with similar inoculation:  Irradiated mice: K 29, D 29, D  53, 
diffuse myelosis; D  54, myeloma.  Unlrradiated mice: D  136, mydoma; K  147 
and K 147, negative. 
(c)  Passage IIIa with similar inoculation:  Irradiated mice: D 21, D 21, K 21, 
D  24, diffuse mydosis.  Unirradiated mice: D  84, D  85, mydoma; K  143  and 
K  143, negative. 
The obvious explanation of these observations is that resistant mice 
destroy many of  the  inoculated malignant  myelocytes and  a  small 
number of these ceils multiply and form tumors in  sites other  than 
the spleen and liver; in the latter organs they perish. 
In  one  experiment  the  rSle  of  resistance  in  the  pathogenesis  of 
myelosis  was  tested  by  inoculating  mice  whose  resistance  was  de- 
creased by varying amounts of X-rays.  All mice used in this experi- 
ment were approximately 3 months of age and they were members of 
the same family (At).  The result of this experiment was as follows: 
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The increase in the number of mice with diffuse myelosis and in the 
number of successful inoculations suggests that the smallest dose of 
X-rays that  increases susceptibility to  transmissible  myelosis is  ap- 
proximately 100 r  (cf. 5). 
Blood Changes 
Since the diagnosis of myelosls of Strain Ar  117  can be made by 
recognition of one or two malignant cells in the blood smear it seemed 
superfluous  to  undertake  an  elaborate  quantitative  study  of mor- 
phological  changes in  the  circulating blood.  Two  procedures were 
used to obtain malignant cells as free from other cells as possible:  (a) 
inoculation  of mice  whose  blood-forming  tissues  were  depleted  by 
irradiation;  (b)  production  of  tumor  by  subcutaneous  or intraperi- 
toneal inoculation of the  neoplastic  blood  ceils.  These procedures 
showed that the malignant cells of Strain Ar 117 are myelocytes with 
coarse  basophile  granules  that  differ  morphologically  from  non- 
malignant immature myeloid cells (Figs.  2, 3,  11 to 16). 
The size of these cells in fixed smears stained with Wright and Giemsa  solutions 
varies greatly; their diameter is from 6 to 14/~, with an average of about 10~.  The 
nucleus is vesicular or slightly indented or lobed.  The cytoplasm is slightly or 
moderately basophilic and contains coarse granules that fail to stain with eosin 
and hematoxylin,  but stain readily with Azure II.  In blood smears there are often 
seen detached cytoplasmic masses with basophilic granules, as shown in Figs. i 
and 2.  The color of these granules varies somewhat in preparations stained with 
Romanowsky dyes; it is usually dark purple and sometimes it is reddish or very 
dark and almost black.  They do not give the oxydase reaction with Schultze's 
indophenyl blue. 
It  is  doubtful  whether  the  mouse  possesses  basophile  granular 
leukocytes (mast cells), such as are found in man (8), but the common 
promyelocytes  of  the  mouse  have  basophile  granules  somewhat 
smaller than those of the basophile myelocyte  of Strain Ar 117 (Fig. 5). 
Tissue mast cells, readily demonstrable in lymph nodes of the mouse 
stained  with  eosin-azure  according  to  1VIaximow, and  occasionally 
seen in smears of lymph node, spleen, or heart blood post mortem, are 
much larger than myelocytes, their granules are much more abundant 
and  more darkly stained (Fig.  6).  Transitional  forms between the 
tissue  mast  cells  and  the  granular leukocytes of the  bone  marrow 
were never seen. i.  FVR~  437 
In view of these considerations  the  characteristic  cell of Strain  Ar 
117 may be regarded as a pathological  (malignant)  myelocyte. 
The number of these cells in the blood stream  of the mouse with the 
spontaneous disease was small  (9.5 per cent).  The  blood smears of 
irradiated  mice that were inoculated intravenously showed, however, 
numerous  basophile myelocytes and  almost  no other  cells.  In  mice 
inoculated  subcutaneously  or  intraperitoneally  the  blood  appeared 
normal during a period of several months, but often there was terminal 
leukemia.  The blood smears of mice with multiple myeloma were, in 
most  instances,  free  from  basophile  myelocytes.  Table  VII  shows 
some figures  that  illustrate  these  observations.  Myelosis caused by 
Strain Ar 117 is associated with severe anemia. 
Fig. 4 shows the blood smear of a mouse with spontaneous myeloid leukemia 
(No. M 372).  Transmission of this instance of myeloid leukemia was attempted 
by inoculation of 79 mice, including 43 irradiated  mice and  eleven unirradiated 
dosely related mice, but without success. 
Anatomical Changes; Observation on the Pathogenesis 
The experiments described indicate that the myeloid ceils in the new 
host  originate  from  those  that  are  introduced  and  are  not  derived 
from  those of the inoculated animal.  (a)  Transmission  is only suc- 
cessful  with  viable  cells.  (b)  It  is  more  successful  in  mice  whose 
blood-forming organs have been injured than  in mice with uninjured 
blood-forming organs.  (c) Tumors composed of cells indistinguishable 
from those injected are formed at the site of injection.  The anatom- 
ical  changes,  however,  differ  somewhat,  according  to  the  route  of 
introduction. 
In  all  instances  in  which subcutaneous inoculation  was successful 
there was a tumor at the site of injection (Figs. 8, 21). 
These tumors were just palpable from 6 to 12 weeks  after inoculation and grew 
slowly until they reached from 3 to 5 cm. in diameter.  The affected mice died 
from 3 to 5 months after the injection.  Large subcutaneous tumors often ulcer- 
ated and in a small number of mice they regressed.  From the subcutaneous tissue 
the tumors occasionaUy  invaded by continuity the peritoneal and pleura1 cavities. 
Here they formed diffuse infiltrations or tumor nodules Upon the peritoneal and 
pleursl surfaces and were associated with milky effusions  in large quantity.  Smear 
preparations of this effusion (Fig. 3) showed basophfle myelocytes and a few very 
large mononuclear ceils which were probably  desquamated mesothdial  cells, but 438 
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no microorganisms.  Distant foci of metastases were found in mice that died or 
were killed at an advanced stage of the disease.  The smears from the blood of 
these mice appeared  normal or more  often in the terminal  stage  of the illness 
showed  basophile  myelocytes.  Metastatic infiltrations  consisted  of  multiple 
white, firm tumors similar to the primary tumors and they were found attached to 
the bones, for example the rib, mandible, vertebra,  bones of the skull and of the 
extremities, or in muscles and viscera.  There was often mild diffuse myelosis of 
spleen and liver. 
After intraperitoneal inoculation there was extensive distention of 
the abdomen  caused by the formation of numerous partly confluent 
tumors attached to the mesentery, diaphragm, and peritoneum (Fig. 
9).  In the peritoneal cavity there was much milky effusion in which 
the cells were largely basophile myelocytes (Fig. 3).  Blood invasion 
and  formation of metastatic  loci were  similar to  those  observed  in 
mice injected subcutaneously. 
After intravenous inoculation the changes were different in mice that 
died from 2 to 5 weeks after injection, from those in mice that died at 
a  later date, but the time relation is only approximate.  The former 
developed  diffuse leukemic  myelosis  (Fig.  7);  the  latter  developed 
myelomata with  or  without  the  diffuse systemic disease  (Fig.  10). 
In order to study the early manifestations of the disease, irradiated 
mice inoculated intravenously were killed 4,  8,  12,  and 18 days after 
inoculation. 
As early as 4 days after the inoculation, basophile myelocytes were numerous 
in the pulp of the spleen.  Their number was considerable 8 days after injection 
and they began to accumulate in the sinusoids of the liver and in the bone marrow. 
Their number per unit area was greatest in the spleen (Fig. 19), Mmost as great 
in the bone marrow (Fig. 22), and much less in the liver (Fig. 18).  They multi- 
plied in these sites by mitosis.  As they increased in the pulp of the spleen the 
lymphoid follicles became smaller.  In some mice mitosis was abundant in the 
lymphoid tissues, apparently as the result of regeneration following injury caused 
by X-rays.  The malignant myeloid cells showed progressive growth in the sinus- 
oids of the spleen.  These became distended with basophile myelocytes and con- 
rained only a few erythrocytes.  In the lymph nodes there was slight accumulation 
of malignant myeloid cells in the lymph sinuses (Fig. 20).  In several mice with 
diffuse myelosis there was a diffuse infiltration  about the thoracic  vertebrae and 
costovertebral  angle, involving the muscle tissue and often causing weakness of 
hind legs. j.  FURTH  441 
DISCUSSION 
The  experiments described here bring  experimental proof for the 
assumption that myeloid leukemia of a  mammal (mouse) is  a  neo- 
plasm.  The  malignant  cells  of  the  strain  described  are  basophile 
myelocytes and they produce the systemic disease with leukemia but 
with no tumor formation in some animals, and multiple myeloma alone 
in others. 
The  strain  described  has  well  defined  characteristics  that  have 
remained constant throughout this study.  These are:  morphological 
peculiarities of the malignant myelocytes, relatively chronic course of 
illness, ability to form tumors in the injected subcutaneous tissue with 
little  tendency to invade the circulating blood.  It is not probable 
that all myeloid leukemias of mice that will prove transmissible will 
behave in the same way.  Experience with five strains of lymphoid 
leukemia (5)  points  to  the contrary, since careful analysis of these 
transmissible strains has revealed distinguishing characters in each. 
More recent experience with lymphoid leukemia of mice has confirmed 
these observations.  Several strains have been observed that did not 
possess  the ability to form tumors in the subcutaneous tissue;  one 
strain was associated with icterus and erythroblastosis. 
An explanation of the difficulty of transmitting myeloid neoplasms 
is  desirable  since  procedures  such  as  those  successfully applied  to 
spontaneous myelosis Ar  117 have  failed  in  numerous  instances of 
similar disease. 
Two factors are significant in determining whether diffuse myelosis 
or myeloma is produced; namely, the route of entry and the resistance 
of the host.  A third factor, the inoculating dose, has been discussed 
in  the  text.  Spontaneous  multiple myelOma may b,c  either multi- 
centric in origin, such as the bone sarcoma produced by irradiation 
(of. Martland (9)) or may be unicentric and develop after intravenous 
dissemination  as  in  our  resistant  mice.  Studies  of  lymphomatosis 
(of. 5)  indicate that there is a  fourth factor that is probably highly 
significant in determining the type of  myelosis; namely,  the  char- 
acter of the malignant myeloid cells.  This  factor can be  revealed 
only by transmission experiments made with several strains of myelo- 
sis, under identical conditions. 442  TRANSMISSION  OF  MYELOID  LEUKEMIA  OF  MICE 
The experimental disease produced by the malignant cells may be 
acute and destroy the mouse within from 2 to 3 weeks, or it may be 
chronic, causing the frst manifestations of illness after about 2 months, 
progressing slowly, and causing the death of the animal from 4 to 5 
months after inoculation.  Variations in the route of entry, resistance 
of the host, and inoculating dose may account for these differences. 
Thus the classification of leukemias into acute and chronic forms is 
highly arbitrary and does not distinguish different types of diseases 
(of.  5). 
A single factor, e.g.  resistance of the host, may delay the course of 
illness and modify its type.  It has been shown that after intravenous 
inoculation  with  a  large  dose,  irradiated  mice  (animals  with  low 
resistance) die within 2 to 3 weeks with systemic leukemic myelosis, 
whereas unirradiated mice of  the  same  moderately resistant  stock 
develop, instead of systemic myelosis, multiple myeloma.  Evidently 
the resistant mice employed had the ability to destroy the malignant 
cells in the spleen and liver, but they were unable to cope with the 
malignant cells that lodged in some tissues favorable for their growth 
where they multiplied and produced tumors.  The soil favorable to 
the best growth may differ with each malignant cell and may deter- 
mine some of the characteristic features of the strain.  For example, 
the malignant myelocytes of Strain Ar 117 grow well in areolar and 
muscle tissue; the malignant lymphocytes of our Strain Rg 10 favor 
the ovaries, and  bilateral ovarian lymphosarcoma may be the only 
gross evidence of successful inoculation with this strain  (of.  5). 
Leukemias and  tumors  composed of either  myeloid or lymphoid 
blood cells are similar malignant diseases, the manifestations of which 
depend on numerous factors, for example (a)  character of the malig- 
nant cell, (b) route of entry (point of origin), (c) resistance of the host, 
(d) inoculating dose (i.e.  number of cells that have undergone malig- 
nant transformation).  The observation that with greatly decreased 
doses the course of the disease is only slightly lengthened is significant 
in relation to  the effect of X-rays in leukemia.  Irradiation of the 
entire body of leukemic mice with/(-rays and radium prolongs the 
life of the animals, probably because these rays destroy many malig- 
nant blood cells  (10). j.  ZUl~  443 
SUMMARY 
A transmissible strain of myeloid leukemia of mice is described.  It 
can be readily passed from diseased to healthy mice by the transfer of 
tissues that contain live cells; but inoculation fails when the latter are 
not present. 
Inoculation is successful in almost every mouse whose resistance is 
lowered by X-rays.  It is often successful in mice related to the animal 
in which the spontaneous leukemia took its origin, and occasionally 
successful in mice unrelated to it. 
The systemic diffuse disease (myeloid leukemia) is produced only by 
intravenous  inoculation  with  relatively  large  doses,  whereas  sub- 
cutaneous or intraperitoneal inoculation results in the formation of 
tumors  composed of  myelocytes with  basophile  granules,  in  other 
words malignant blood cells of the strain  described. 
Intravenous inoculation with  small doses in  susceptible mice, or 
similar inoculation with larger doses in somewhat resistant mice, re- 
sults in  the formation of tumors composed of myelocytes (multiple 
myeloma). 
CONCLUSIONS 
Experiments demonstrate that  transmissible myeloid leukemia of 
mice  is  a  neoplasm.  The  malignant  immature  granulocytes  that 
produce the systemic disease may also produce tumors (multiple my- 
eloma). 
Some factors that determine the type of transmitted myelosis are 
(a)  the resistance of the host, (b) the route of entry, (c) the character 
of the malignant cell, and, probably, (d) the inoculating dose. 
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EXPLANATION OF PLATES 
All  blood  smears  were  stained  with  Wright  and  Giemsa  solutions,  and  the 
sections  with  eosin  and  Azure  II solutions.  The  magnifications stated  are  ap- 
proximate. 
PLATE 17 
F~G.  1.  Blood  smear from spontaneous  myeloid leukemia  of Mouse  Ar  117, 
showing  two  myelocytes  with  hasophlle  granules,  one  imm~tture  polymorpho- 
nuclear  leukocyte,  one  mature  polymorphonuclear  leukocyte,  one  unidentified 
large mononuclear cell, a small lymphocyte, and a cytoplasmic mass with basophile 
granules.  X 910. 
Fio.  2.  Transmitted  myeloid  leukemia  with  myelocytes,  an  unidentified 
mononudear  cell,  and  a  cytoplasmic mass with  basophilie granules  in  the field. 
X  910. 
FIO. 3.  Smear of peritoneal effusion that accompanied abdominal myelomatosis 
produced by transmission.  X  910. 
FIo.  4.  Blood  smear in spontaneous  myeloid leukemia of Mouse Af 372;  (a) 
myeloblast;  (b) and  (6) myelocytes; (d)  ~rnmature polymorphonuclear leukocyte; 
(e) mature polymorphonuclear leukocytes; (f) cytoplasmic mass containing neutro- 
phile granules.  X  910. 
FIG. 5.  A normal myelocyte from a  smear of the spleen of a  mouse with non- 
malignant myeloid metaplasia.  X  910. 
FIG. 6.  Tissue mast cell from the lymph node of a  healthy mouse.  ×  910. 
PLATE 18 
Fro.  7.  Diffuse mydosis  (myeloid leukemia) produced by transfer of myeloid 
cells to an irradiated mouse.  The spleen is greatly enlarged, the liver is moder- 
ately enlarged, and there are numerous small hemorrhagic infarcts in the lung. 
FIG.  8.  Myeloid  tumor  produced  by  subcutaneous  inoculation.  The  tumor 
occupies most of the right lateral aspect of the mouse.  There is no evidence of 
metastases. 
FIG. 9.  Abdominal myelomatosis produced by intraperitoneal injection.  The 
abdominal cavity is filled with  tumor masses, diffusely infiltrating the mesentery 
and omentum. 
FIG.  10.  Multiple myelomata in the left submaxillary region, ribs, vertebrae, 
muscles of the abdominal wall, and extremities, produced by intravenous inocula- 
tion of a  moderately resistant, unirradiated mouse. j.  ~  445 
P~,a-E  19 
FIG. 11.  Myeloid leukemia produced by transmission to an irradiated mouse. 
There are nine myelocytes with basophile granules in the field.  X 400. 
FIGS. 12 to 16.  Myelocytes with basophile granules and one neutrophile poly- 
morphonuclear leukocyte  (Fig.  13).  Magnifications Figs.  12, 13, 15,  16 ×  850; 
Fig. 14  ×  4OO. 
FIG. 17.  The liver of a mouse (No. Ar 117) with spontaneous myeloid leukemi~t~ 
X  200. 
FIo. 18.  Higher magnification of the liver of a mouse with transmitted myeloid 
leukemia showing distention of the sinusoids by immature myelold cells with com- 
pression of the liver cells.  X 750. 
P~T~ 20 
Fro.  19.  Extensive infiltration of the spleen with compression of a  lymphoid 
follicle in a mouse with myeloid leukemia produced by transmission.  ×  180. 
FIG. 20.  Accumulation of immature myeloid cells in the sinuses of a lymph node 
in a mouse (No. Ar 117) with spontaneous myeloid leukemia.  ×  200. 
FIG. 21.  Immature myeloid cells  infiltrating the abdominal muscle after sub- 
cutaneous inoculation.  X  150. 
FIG. 22.  Extensive infiltration of the bone marrow with myelocytes containing 
coarse basophile granules in myeloid leukemia caused by transmission.  ×  600. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL. 61  PLATE 17 
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